Employing modeling and simulation techniques to explore the robustness of TTE analysis under different assumptions about treatment patterns, adherence, and disease progression rates could help identify potential biases and limitations of the approach and inform future trial design
Originally developed by Eli Lilly as a next-generation obesity treatment, Retatrutide has captured attention from addiction researchers who noticed something remarkable in early trial participants: many spontaneously reported diminished interest in alcohol without any specific intervention targeting drinking behaviour
What makes the triple agonist approach so compelling is how it leverages glucagon to increase energy expenditure alongside the appetite suppressing effects of GLP-1 and GIP
Bacteriostatic water should be stored at room temperature (15-30C) before opening
Label every aliquot with concentration, batch, date, and storage temperature
Repurposing GLP-1 Receptor Agonists for Parkinsons Disease: Current Evidence and Future Opportunities